Latest news with #Levonorgestrel
Miami Herald
27-05-2025
- Health
- Miami Herald
Convenience stores eyed as way to provide morning-after pill
St. PAUL, Minn., May 27 (UPI) -- Women's health advocates say they want to expand the availability of morning-after pills to convenience stores as new state abortion laws sow confusion about their legality and pharmacies are closing nationwide. Emergency contraception deserts are arising in many areas of the United States where morning-after pills, although still legal everywhere, have become almost impossible to find due to a combination of misconceptions about their function and the ongoing drug store closures, healthcare experts told UPI. Some suggest that wider availability of morning-after pills for women at convenience stores and other non-traditional outlets, such as gas stations, grocery stores, corner delis, travel retailers and hotels, could ease the problem. Levonorgestrel, also known as "Plan B," or the morning-after pill, is a first-line oral emergency contraceptive pill approved from the U.S. Food and Drug Administration and the World Health Organization to prevent pregnancy. It is to be used within 72 hours of unprotected sexual intercourse or when a presumed contraceptive failure has occurred. It has an average cost about $40 to $50, with generics generally costing less at about $11 to $45. Approved in 2007 Levonorgestrel earned FDA approval to be sold over the counter without a prescription in 2007 after the agency deemed it to be safe following years of debate. Since then, it has been available without a prescription at drug stores alongside male contraceptives, such as condoms. But while condoms are widely available in many different settings, women's health advocates are warning that the lack of similar availability for Plan B pills outside traditional pharmacies has created emergency contraception deserts in many areas. Adding to the problem is confusion about how Plan B pills function and whether they're still legal in the wake of the Supreme Court's landmark 2022 Dobbs vs. Jackson Women's Health Organization decision thatallowed states to enact local abortion bans. Uncertainty has arisen in states with the toughest abortion restrictions about whether the pills even remain legal as people confuse levonorgestrel, which prevents pregnancy, with mifepristone and misoprostol, which induce medical abortions, according to the women's health advocates. Polls indicate that as many as 73% of people incorrectly think morning-after pills can end a pregnancy in its early stages. In fact, the right to such contraception is currently protected by two other landmark Supreme Court decisions, Griswold vs. Connecticut (1965) and Eisenstadt vs. Baird (1972), but this confusion is believed to have led to declines in their use since Dobbs, they argue. Challenging economics They also point to the challenging economics of the retail pharmacy industry. Walgreens, for instance, announced in October that it will close roughly 1,200 of its stores through 2027 and seeks to close at least 500 stores by the end of 2025 alone. It says one-quarter of its roughly 8,700 U.S. store locations are unprofitable. About one-third of all U.S. pharmacies have closed since 2010 due to mergers of large pharmacy chains and the closure of stores deemed not profitable enough, according to a study published last year. As these factors accelerate, some 7,000 U.S. ZIP codes in both urban and rural areas now qualify as emergency contraception deserts in which "healthcare services are lacking and there are few or no drug stores to fulfill the needs of the approximately 23 million women of childbearing age who live there," according to Cadence OTC, an Oakland, Calif.-based public benefit company that makes and markets a brand of levonorgestrel called "Morning After Pill." Cadence officials say they have spent the last few years working hard to convince convenience retailers that stocking Morning After Pill benefits both their bottom lines and the health of their communities. They have so far succeeded in getting the product into 11,000 locations in 48 states after forging a partnership with Lil' Drug Store Products, the nation's top supplier of health and beauty care products to convenience stores. Sales in remote areas "A lot of college campuses and military bases are in remote areas and are filled with young people, so these are priorities for contraceptive access," the company said in a statement issued to UPI. "C-stores are in every neighborhood and they are open long hours." Stocking emergency contraceptives makes sense for convenience stores as a way to replace revenue lost as cigarette purchases decline, Cadence said, adding, "Urgent healthcare products are a logical expansion space for C-stores, and the profit margins are generally higher than food and soft drinks. "Ninety percent of C-stores already carry condoms, so it makes sense to offer female contraceptives. as well." The challenge "is to increase awareness among consumers to think of C-stores for these healthcare items," company officials said in a statement. "Many C-stores are excited about playing a more important role in serving young women, leaning into urgent OTC healthcare is a smart business strategy." Health benefit One gynecologist who has studied the availability of emergency contraception in the aftermath of the Dobbs decision said the push to get morning-after pills into convenience stores would provide a public health benefit. Dr. Frank "Will" Williams III, who specializes in treating complicated pregnancies for Ochsner Health in New Orleans, co-authored a 2023 study that found only 35% of locally owned, independent pharmacies in the city had emergency contraception in stock. They were also much more likely than chain stores to keep the product behind the counter, require identification and carry no brand that cost under $50. "The independent pharmacies are the ones who are not likely to have a gaggle of lawyers on retainer who can tell them, 'Yes, emergency contraception is fine, they're not discussed at all in any of the abortion legislation, you guys can keep going with this,'" Williams told UPI. "They didn't have that luxury, so when Dobbs came through, that's where we really saw an absence of access to contraception." Now with many chain-owned pharmacies closing as well, the push to expand emergency contraception into non-traditional retail venues is needed, he said. Greater accessibility "If I'm traveling and need ibuprofen, I can find it a grocery store or convenience store, so there's no reason why that can't also be true for emergency contraception," Williams said. "Whatever we can do to make sure that people have accessible options regarding their health seems like a win to me." Agreeing is Dima Mazen Qato, an associate professor at the University of Southern California's Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and a senior scholar at the USC Schaeffer Center for Health Policy & Economics. Qato has researched the causes behind the wave of pharmacy closures and their effects on socioeconomic and racial health disparities across the country. Getting emergency contraception into non-traditional venues "makes sense, although I don't know what the price point is for it to be affordable and to actually be used by those who need it," she told UPI. "It's important to make sure it's affordable at these different access points, and also that there's no ID required -- that's just available like anything else." She added it's "definitely a great way to distribute emergency contraception, especially in states that, since Dobbs, have banned or partially banned abortion care. I think any effort to expand access to emergency contraception is needed across the country." Copyright 2025 UPI News Corporation. All Rights Reserved.
Yahoo
27-05-2025
- Business
- Yahoo
Convenience stores eyed as way to provide morning-after pill
St. PAUL, Minn., May 27 (UPI) -- Women's health advocates say they want to expand the availability of morning-after pills to convenience stores as new state abortion laws sow confusion about their legality and pharmacies are closing nationwide. Emergency contraception deserts are arising in many areas of the United States where morning-after pills, although still legal everywhere, have become almost impossible to find due to a combination of misconceptions about their function and the ongoing drug store closures, healthcare experts told UPI. Some suggest that wider availability of morning-after pills for women at convenience stores and other non-traditional outlets, such as gas stations, grocery stores, corner delis, travel retailers and hotels, could ease the problem. Levonorgestrel, also known as "Plan B," or the morning-after pill, is a first-line oral emergency contraceptive pill approved from the U.S. Food and Drug Administration and the World Health Organization to prevent pregnancy. It is to be used within 72 hours of unprotected sexual intercourse or when a presumed contraceptive failure has occurred. It has an average cost about $40 to $50, with generics generally costing less at about $11 to $45. Approved in 2007 Levonorgestrel earned FDA approval to be sold over the counter without a prescription in 2007 after the agency deemed it to be safe following years of debate. Since then, it has been available without a prescription at drug stores alongside male contraceptives, such as condoms. But while condoms are widely available in many different settings, women's health advocates are warning that the lack of similar availability for Plan B pills outside traditional pharmacies has created emergency contraception deserts in many areas. Adding to the problem is confusion about how Plan B pills function and whether they're still legal in the wake of the Supreme Court's landmark 2022 Dobbs vs. Jackson Women's Health Organization decision that allowed states to enact local abortion bans. Uncertainty has arisen in states with the toughest abortion restrictions about whether the pills even remain legal as people confuse levonorgestrel, which prevents pregnancy, with mifepristone and misoprostol, which induce medical abortions, according to the women's health advocates. Polls indicate that as many as 73% of people incorrectly think morning-after pills can end a pregnancy in its early stages. In fact, the right to such contraception is currently protected by two other landmark Supreme Court decisions, Griswold vs. Connecticut (1965) and Eisenstadt vs. Baird (1972), but this confusion is believed to have led to declines in their use since Dobbs, they argue. Challenging economics They also point to the challenging economics of the retail pharmacy industry. Walgreens, for instance, announced in October that it will close roughly 1,200 of its stores through 2027 and seeks to close at least 500 stores by the end of 2025 alone. It says one-quarter of its roughly 8,700 U.S. store locations are unprofitable. About one-third of all U.S. pharmacies have closed since 2010 due to mergers of large pharmacy chains and the closure of stores deemed not profitable enough, according to a study published last year. As these factors accelerate, some 7,000 U.S. ZIP codes in both urban and rural areas now qualify as emergency contraception deserts in which "healthcare services are lacking and there are few or no drug stores to fulfill the needs of the approximately 23 million women of childbearing age who live there," according to Cadence OTC, an Oakland, Calif.-based public benefit company that makes and markets a brand of levonorgestrel called "Morning After Pill." Cadence officials say they have spent the last few years working hard to convince convenience retailers that stocking Morning After Pill benefits both their bottom lines and the health of their communities. They have so far succeeded in getting the product into 11,000 locations in 48 states after forging a partnership with Lil' Drug Store Products, the nation's top supplier of health and beauty care products to convenience stores. Sales in remote areas "A lot of college campuses and military bases are in remote areas and are filled with young people, so these are priorities for contraceptive access," the company said in a statement issued to UPI. "C-stores are in every neighborhood and they are open long hours." Stocking emergency contraceptives makes sense for convenience stores as a way to replace revenue lost as cigarette purchases decline, Cadence said, adding, "Urgent healthcare products are a logical expansion space for C-stores, and the profit margins are generally higher than food and soft drinks. "Ninety percent of C-stores already carry condoms, so it makes sense to offer female contraceptives. as well." The challenge "is to increase awareness among consumers to think of C-stores for these healthcare items," company officials said in a statement. "Many C-stores are excited about playing a more important role in serving young women, leaning into urgent OTC healthcare is a smart business strategy." Health benefit One gynecologist who has studied the availability of emergency contraception in the aftermath of the Dobbs decision said the push to get morning-after pills into convenience stores would provide a public health benefit. Dr. Frank "Will" Williams III, who specializes in treating complicated pregnancies for Ochsner Health in New Orleans, co-authored a 2023 study that found only 35% of locally owned, independent pharmacies in the city had emergency contraception in stock. They were also much more likely than chain stores to keep the product behind the counter, require identification and carry no brand that cost under $50. "The independent pharmacies are the ones who are not likely to have a gaggle of lawyers on retainer who can tell them, 'Yes, emergency contraception is fine, they're not discussed at all in any of the abortion legislation, you guys can keep going with this,'" Williams told UPI. "They didn't have that luxury, so when Dobbs came through, that's where we really saw an absence of access to contraception." Now with many chain-owned pharmacies closing as well, the push to expand emergency contraception into non-traditional retail venues is needed, he said. Greater accessibility "If I'm traveling and need ibuprofen, I can find it a grocery store or convenience store, so there's no reason why that can't also be true for emergency contraception," Williams said. "Whatever we can do to make sure that people have accessible options regarding their health seems like a win to me." Agreeing is Dima Mazen Qato, an associate professor at the University of Southern California's Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and a senior scholar at the USC Schaeffer Center for Health Policy & Economics. Qato has researched the causes behind the wave of pharmacy closures and their effects on socioeconomic and racial health disparities across the country. Getting emergency contraception into non-traditional venues "makes sense, although I don't know what the price point is for it to be affordable and to actually be used by those who need it," she told UPI. "It's important to make sure it's affordable at these different access points, and also that there's no ID required -- that's just available like anything else." She added it's "definitely a great way to distribute emergency contraception, especially in states that, since Dobbs, have banned or partially banned abortion care. I think any effort to expand access to emergency contraception is needed across the country."
UPI
27-05-2025
- Health
- UPI
Convenience stores eyed as way to provide morning-after pill
St. PAUL, Minn., May 27 (UPI) -- Women's health advocates say they want to expand the availability of morning-after pills to convenience stores as new state abortion laws sow confusion about their legality and pharmacies are closing nationwide. Emergency contraception deserts are arising in many areas of the United States where morning-after pills, although still legal everywhere, have become almost impossible to find due to a combination of misconceptions about their function and the ongoing drug store closures, healthcare experts told UPI. Some suggest that wider availability of morning-after pills for women at convenience stores and other non-traditional outlets, such as gas stations, grocery stores, corner delis, travel retailers and hotels, could ease the problem. Levonorgestrel, also known as "Plan B," or the morning-after pill, is a first-line oral emergency contraceptive pill approved from the U.S. Food and Drug Administration and the World Health Organization to prevent pregnancy. It is to be used within 72 hours of unprotected sexual intercourse or when a presumed contraceptive failure has occurred. It has an average cost about $40 to $50, with generics generally costing less at about $11 to $45. Approved in 2007 Levonorgestrel earned FDA approval to be sold over the counter without a prescription in 2007 after the agency deemed it to be safe following years of debate. Since then, it has been available without a prescription at drug stores alongside male contraceptives, such as condoms. But while condoms are widely available in many different settings, women's health advocates are warning that the lack of similar availability for Plan B pills outside traditional pharmacies has created emergency contraception deserts in many areas. Adding to the problem is confusion about how Plan B pills function and whether they're still legal in the wake of the Supreme Court's landmark 2022 Dobbs vs. Jackson Women's Health Organization decision that allowed states to enact local abortion bans. Uncertainty has arisen in states with the toughest abortion restrictions about whether the pills even remain legal as people confuse levonorgestrel, which prevents pregnancy, with mifepristone and misoprostol, which induce medical abortions, according to the women's health advocates. Polls indicate that as many as 73% of people incorrectly think morning-after pills can end a pregnancy in its early stages. In fact, the right to such contraception is currently protected by two other landmark Supreme Court decisions, Griswold vs. Connecticut (1965) and Eisenstadt vs. Baird (1972), but this confusion is believed to have led to declines in their use since Dobbs, they argue. Challenging economics They also point to the challenging economics of the retail pharmacy industry. Walgreens, for instance, announced in October that it will close roughly 1,200 of its stores through 2027 and seeks to close at least 500 stores by the end of 2025 alone. It says one-quarter of its roughly 8,700 U.S. store locations are unprofitable. About one-third of all U.S. pharmacies have closed since 2010 due to mergers of large pharmacy chains and the closure of stores deemed not profitable enough, according to a study published last year. As these factors accelerate, some 7,000 U.S. ZIP codes in both urban and rural areas now qualify as emergency contraception deserts in which "healthcare services are lacking and there are few or no drug stores to fulfill the needs of the approximately 23 million women of childbearing age who live there," according to Cadence OTC, an Oakland, Calif.-based public benefit company that makes and markets a brand of levonorgestrel called "Morning After Pill." Cadence officials say they have spent the last few years working hard to convince convenience retailers that stocking Morning After Pill benefits both their bottom lines and the health of their communities. They have so far succeeded in getting the product into 11,000 locations in 48 states after forging a partnership with Lil' Drug Store Products, the nation's top supplier of health and beauty care products to convenience stores. Sales in remote areas "A lot of college campuses and military bases are in remote areas and are filled with young people, so these are priorities for contraceptive access," the company said in a statement issued to UPI. "C-stores are in every neighborhood and they are open long hours." Stocking emergency contraceptives makes sense for convenience stores as a way to replace revenue lost as cigarette purchases decline, Cadence said, adding, "Urgent healthcare products are a logical expansion space for C-stores, and the profit margins are generally higher than food and soft drinks. "Ninety percent of C-stores already carry condoms, so it makes sense to offer female contraceptives. as well." The challenge "is to increase awareness among consumers to think of C-stores for these healthcare items," company officials said in a statement. "Many C-stores are excited about playing a more important role in serving young women, leaning into urgent OTC healthcare is a smart business strategy." Health benefit One gynecologist who has studied the availability of emergency contraception in the aftermath of the Dobbs decision said the push to get morning-after pills into convenience stores would provide a public health benefit. Dr. Frank "Will" Williams III, who specializes in treating complicated pregnancies for Ochsner Health in New Orleans, co-authored a 2023 study that found only 35% of locally owned, independent pharmacies in the city had emergency contraception in stock. They were also much more likely than chain stores to keep the product behind the counter, require identification and carry no brand that cost under $50. "The independent pharmacies are the ones who are not likely to have a gaggle of lawyers on retainer who can tell them, 'Yes, emergency contraception is fine, they're not discussed at all in any of the abortion legislation, you guys can keep going with this,'" Williams told UPI. "They didn't have that luxury, so when Dobbs came through, that's where we really saw an absence of access to contraception." Now with many chain-owned pharmacies closing as well, the push to expand emergency contraception into non-traditional retail venues is needed, he said. Greater accessibility "If I'm traveling and need ibuprofen, I can find it a grocery store or convenience store, so there's no reason why that can't also be true for emergency contraception," Williams said. "Whatever we can do to make sure that people have accessible options regarding their health seems like a win to me." Agreeing is Dima Mazen Qato, an associate professor at the University of Southern California's Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and a senior scholar at the USC Schaeffer Center for Health Policy & Economics. Qato has researched the causes behind the wave of pharmacy closures and their effects on socioeconomic and racial health disparities across the country. Getting emergency contraception into non-traditional venues "makes sense, although I don't know what the price point is for it to be affordable and to actually be used by those who need it," she told UPI. "It's important to make sure it's affordable at these different access points, and also that there's no ID required -- that's just available like anything else." She added it's "definitely a great way to distribute emergency contraception, especially in states that, since Dobbs, have banned or partially banned abortion care. I think any effort to expand access to emergency contraception is needed across the country."
Hindustan Times
30-04-2025
- Hindustan Times
After record haul, illegal MTP kit supplier's house raided in Haryana's Karnal
Hours after the largest-ever haul of more than 5,000 abortion kits in Haryana, where the sex ratio at birth is among the worst in the country, a state government team raided the house a medical supplier, Ravinder Kumar, in Karnal on Tuesday night and seized large quantities of undocumented drugs. A search is on for the absconding supplier after CCTV footage shows him and his family members fleeing with large boxes. A joint team of the health department, food and drug administration (FDA), and Haryana State Narcotics Control Bureau (HSNBC) raided Ravinder Kumar's house after 5,805 medical termination of pregnancy (MTP) kits were recovered in Kaithal on Tuesday morning. Kaithal-based medical representative Vikas Bansal was arrested and booked after the recovery. Haryana state drug controller Manmohan Taneja said that during interrogation, Bansal admitted that he had procured the kits from Ravinder Kumar in Karnal. When the joint team, including drug control officers of Kaithal and Karnal, an HSNCB sub-inspector and the Kunjpura senior medical officer, reached Ravinder Kumar's house at Shiv Colony in Karnal in the evening, they found it locked. Ravinder was untraceable and his mobile phone was switched off, a member of the raiding team said. According to the food and drug administration (FDA), the team questioned the tenant, Abhishek Sharma, who disclosed that the premises, comprising two rooms and a kitchen, belongs to Ravinder's brother Yashvinder. 'Yashvinder turned up and said that his brother was unable to come, but did not give any reason. The lock to the premises was opened in the presence of two witnesses. During searches, the team found huge quantities of unaccounted homoeopathic and allopathic drugs,' the FDA official said. When questioned, Yashvinder failed to produce any drug sale licence or purchase record of the stock of medicines seized. Sources said CCTV footage in the area showed Ravinder Kumar fleeing the premises with large boxes. He was accompanied by his family members. The authorities are now on the lookout of the absconding suspect. The items seized under Section 22 (1)(c) or (cc) of the Drugs and Cosmetics Act are 1,000 tablets of Vigueur (Sildenafil Citrate 100mg), 258 tablets of TrustPostpil 72 (Levonorgestrel), 60 pills of Unwanted-72 (Levonorgestrel), 216 Manforce 100 (Sildenafil) and different quantities of German-made Calcium Phosphorica homeopathic medicine. On Tuesday, the team had seized 5,805 MTP kits worth ₹25 lakh of different batches and manufacturers. Of them, 5,745 kits were sealed and seized, and 60 were taken for sampling. According to the health officials, each MTP kit contains a Mifepristone (200mg) tablet and four Misoprostol (200mcg) tablets, both are used for terminating pregnancies and can only be stored or prescribed by registered medical practitioners and that too at authorised medical facilities. Two other types of drugs, Unwanted 72 (660 tablets), and Manforce-100 (3,840 tablets), were also recovered from Bansal's house.
Yahoo
23-04-2025
- Health
- Yahoo
Synthetic hormones and the future of contraception
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying on the same methods. The conventional pill for pregnancy prevention includes brands such as Microgynon or Rigevidon. Alternative options include the hormonal or copper intrauterine device (IUD), injectable contraceptives, the implant, or the vaginal ring. The most prevalent contraceptive pills contain synthetic hormones that emulate the body's natural hormones. These may be predominantly testosterone-based or estrogen-based, each with distinct, nuanced effects. For instance, a pill such as Levonorgestrel tends to have a more testosterone-like effect, including potential side effects such as acne. Meanwhile, the Yasmin pill is more estrogenic, potentially giving clearer skin but increasing the risk of blood clots. Unfortunately, women often receive insufficient information regarding these varied side effects, which are commonly generalised across all pills as headaches, nausea, weight gain, mood swings, tender breasts, or acne. These synthetic hormones function in several ways. Progestin, a mimic of the natural hormone progesterone, thickens cervical mucus to obstruct sperm. The combination pill, which includes both progestin and synthetic estrogen, not only thickens the mucus but also disrupts ovulation. These components are present in oral contraceptives, implants, and hormonal IUDs. The copper IUD operates differently, as copper is toxic to sperm, but it may lead to increased menstrual bleeding. Synthetic hormones can suppress natural hormones and do not always interact identically with the body's receptors. For example, natural progesterone has a calming effect and promotes sleep, whereas the synthetic version, progestin, may bind to incorrect receptors, disrupting the body's balance rather than providing the calming influence of natural progesterone. Moreover, synthetic hormones can influence mental health. Estrogen and serotonin are closely linked, with low estrogen levels correlating with reduced serotonin, leading to emotional blunting. This effect is observed during menopause when estrogen levels decline, resulting in decreased mood and heightened anxiety. Synthetic estrogen, similar to progestin, may not always target the appropriate receptors, causing young women or individuals with female reproductive systems who take the pill to experience emotional effects akin to those of menopause as their bodies produce less natural estrogen in response to the synthetic hormones. In the documentary Pill Revolution, Channel 4 surveyed 4,000 women in the UK and discovered that 64% began using the pill during their school years. Alarmingly, there is a significant research gap on how this might affect brain development in adolescents. The pill is often prescribed with scant information on the potential impact of various synthetic hormones on the body and mind. Of the surveyed women, 77% reported side effects such as weight gain, headaches, decreased mood, and libido. A 2016 Danish study involving over a million women revealed that those using a pill with synthetic progestin were 34% more likely to be prescribed antidepressants within the following year, with users of the hormonal IUD facing a 40% increase. Historical research on birth control was marred by unethical practices. For example, in the 1950s, an asylum in Massachusetts served as a testing ground. Inmates were given high doses of the pill with permission from their families but without their own consent. Three women died from the excessive dosage, and a quarter withdrew from the trial due to headaches and dizziness - symptoms indicative of potential blood clots and strokes. Ideally, the effects of the pill would be studied through randomised control trials with a placebo. However, this approach faces volunteer recruitment challenges, as those seeking contraception wish to ensure pregnancy prevention. Consequently, reliance on surveys of personal experiences with the pill may leave women feeling like experimental subjects in the examination of their bodies. Emerging alternatives include new apps that measure basal body temperature daily. Since ovulation raises body temperature, the app advises the use of a condom during this period. However, factors such as illness or alcohol consumption can affect temperature readings, making these apps just 93% effective. Nonetheless, the onus should not rest solely on women. Ongoing trials are exploring various male contraceptive methods. The NES/T trial in Edinburgh, spanning over a decade, involves a shoulder gel containing progestin and natural testosterone, which significantly reduces sperm count after three months of consistent use. Plan A is another approach, injecting a temporary vasectomy gel into the vas deferens to block sperm, with a subsequent injection available to dissolve the gel. YCT529, still in the experimental phase, targets a receptor involved in sperm function. Whatever the future involves, greater research is needed into birth control. With methods remaining fundamentally unchanged for the past few decades, it is an area of healthcare that has been largely neglected, and the effects of birth control on a person's health and well-being are vastly overlooked. "Synthetic hormones and the future of contraception" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
